Scott T. Rottinghaus Enanta Pharmaceuticals Inc (ENTA) insider trading activity
Scott T. Rottinghaus is Chief Medical Officer of ENANTA PHARMACEUTICALS INC. Currently has a direct ownership of 17,918 shares of ENTA, which is worth approximately $89,231. The most recent transaction as insider was on Dec 06, 2024, when has been sold 866 shares (Common Stock) at a price of $8.06 per share, resulting in proceeds of $6,979. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
17.9K
4.61%
3M change
32.3%
12M change
Total Value Held
$89,231
Scott T. Rottinghaus Transaction History
STR
Scott T. Rottinghaus
Chief Medical Officer
Watertown, MA